FDA GUIDANCENovember 06, 2026
FDA Grants Premarket Approval (PMA P210036): PerClot Absorbable Hemostatic Powder Accessory Tips by Baxter Healthcare Corporation
Affected Product:PerClot Absorbable Hemostatic Powder Accessory Tips
Recalling Firm / Manufacturer:Baxter Healthcare Corporation
Reference / Recall Number:P210036
Executive Summary:
FDA awards Class III Premarket Approval (PMA P210036) for PerClot Absorbable Hemostatic Powder Accessory Tips sponsored by Baxter Healthcare Corporation.
The FDA Center for Devices and Radiological Health has granted Premarket Approval (PMA) for PerClot Absorbable Hemostatic Powder Accessory Tips, classified as a Class III life-supporting or life-sustaining medical device.
PMA Approval Dossier
- PMA Number: P210036
- Applicant: Baxter Healthcare Corporation
- Device Designation: PerClot Absorbable Hemostatic Powder Accessory Tips
- Product Code: LMG
- Decision Code: APPR
Approval was based on rigorous review of valid scientific evidence, including bench testing, animal studies, and human clinical trial outcomes establishing a reasonable assurance of safety and effectiveness.
Official Regulatory Docket:Open Agency Docket